Agios Pharmaceuticals

Agios Pharmaceuticals, founded in 2008 and headquartered in Cambridge, MA, is a large biopharmaceutical company specializing in rare genetic diseases and cellular metabolism. The company is committed to transforming lives through innovative therapies and strong community partnerships.

Company Overview

Agios Pharmaceuticals operates within the Pharmaceuticals industry and was founded in 2008. The company is classified as a large business, employing approximately 509 individuals. Headquartered in Cambridge, Massachusetts, Agios Pharmaceuticals is dedicated to transforming the lives of individuals with genetically defined diseases. The company emphasizes its commitment to scientific innovation and building strong connections with patient communities, healthcare professionals, and partners.

Specialties

Agios Pharmaceuticals specializes in biopharmaceuticals, focusing on rare genetic diseases and cellular metabolism. The company has developed expertise in treating hemolytic anemias and is known for its pioneering leadership in cellular metabolism since its inception. Agios Pharmaceuticals actively engages in partnerships with patient communities and advocacy groups to enhance disease awareness and education.

Products and Pipeline

Agios Pharmaceuticals has developed a first-in-class pyruvate kinase (PK) activator, mitapivat, which targets conditions such as thalassemia and sickle cell disease. The company is committed to advancing drug development and delivery approaches, including support for Investigator Sponsored Trials to enhance scientific knowledge. The pipeline reflects a focus on therapies for rare diseases, particularly those related to hemolytic anemias.

Patient Support Programs

Agios Pharmaceuticals offers comprehensive patient support programs, including disease education and financial assistance for eligible patients. The myAgios patient support services program specifically assists U.S. residents with pyruvate kinase deficiency. Additionally, the company provides educational resources and diagnostic tools for healthcare providers treating rare diseases, ensuring that patients receive the necessary support and information.

Corporate Responsibility and Inclusion

Agios Pharmaceuticals is committed to corporate social responsibility initiatives that align with the United Nations Sustainable Development Goals. The company promotes diversity, equity, and inclusion within its workplace, fostering a welcoming environment for all employees. Agios Pharmaceuticals also emphasizes the importance of making medicines accessible and affordable, with tailored patient assistance programs designed to meet community needs.